Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-21,571
Closed -$676K 153
2017
Q3
$676K Sell
21,571
-2,525
-10% -$85.7K 0.4% 77
2017
Q2
$935 Sell
24,096
-5,325
-18% -$204K 0.48% 51
2017
Q1
$1.15M Buy
+29,421
New +$1.19M 0.58% 57
2015
Q2
$228K Buy
+3,356
New +$237K 0.14% 113
2014
Q4
$4.18M Buy
74,242
+485
+0.7% +$26K 1.46% 13
2014
Q3
$3.35M Buy
73,757
+1,109
+2% +$53.9K 1.23% 21
2014
Q2
$3.75M Buy
72,648
+886
+1% +$43.5K 1.38% 17
2014
Q1
$3.5M Buy
71,762
+1,214
+2% +$58.9K 1.37% 18
2013
Q4
$3.06M Buy
70,548
+420
+0.6% +$17.3K 1.25% 22
2013
Q3
$2.68M Buy
70,128
+891
+1% +$31.4K 1.07% 26
2013
Q2
$2.15M Buy
+69,237
New +$2.07M 0.91% 34

Other funds holding VTRS

FMA Advisory's VTRS Position: Q4 2017 in Review

FMA Advisory sold out of Viatris (VTRS) in Q4 2017, closing a stake of 21,571 shares — an estimated $676K sold.

FMA Advisory first reported a position in VTRS in Q2 2013 and held it in 11 quarters. The position peaked at $4.18M in Q4 2014. 538 funds tracked by Wall St. Rank hold VTRS as of Q4 2017.

  • FMA Advisory reported no remaining Viatris position as of Q4 2017 after selling out during the quarter.
  • FMA Advisory sold 21,571 Viatris shares in Q4 2017, an estimated $676K.
  • FMA Advisory first reported a position in Viatris in Q2 2013 and held it in 11 quarters.
  • FMA Advisory's Viatris position peaked at $4.18M in Q4 2014.
  • 538 funds tracked by Wall St. Rank held Viatris as of Q4 2017.

Based on FMA Advisory's 13F filing for Q4 2017, filed 12 Apr 2021.